Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension

Intensive Care Medicine

Volumn 25, Issue 10, 1999, Pages 1147-1154

  Max, M ^a   Kuhlen, R ^a   Dembinski, R ^a   Rossaint, R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Hypoxic pulmonary vasoconstriction; Nitric oxide; Prostacyclin

Indexed keywords

NITRIC OXIDE; OXYGEN; PROSTACYCLIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; GAS EXCHANGE; HYPOXIC LUNG VASOCONSTRICTION; INHALATIONAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; NONHUMAN; OXYGEN BREATHING; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SWINE;

EID: 0032697180     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340051027     Document Type: Article

References (27)

1. 1. Barman SA (1998) Potassium channels modulate hypoxic pulmonary vasoconstriction. Am J Physiol 275:L64-L70
2. 2. Zapol WM, Jones R (1987) Vascular components in ARDS. Am Rev Respir Dis 136: 471-474
3. 3. Vender RL (1994) Chronic hypoxic pulmonary hypertension. Cell biology to pathophysiology. Chest 106: 236-243
4. 4. Benumof JL (1979) Mechanism of decreased blood flow to atelectatic lung. J Appl Physiol 46: 1047-1048
5. 5. Marshall BE, Marshall C, Magno M, Lilagan P, Pietra GG (1991) Influence of bronchial arterial PO2 on pulmonary vascular resistance. J Appl Physiol 70: 405-415
6. 6. Radermacher P, Santak B, Wüst HJ, Tarnow J, Falke KJ (1990) Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS. Intensive Care Med 16: 227-232
7. 7. Westfelt UN, Lundin S, Stenqvist O (1997) Uptake of inhaled nitric oxide in acute lung injury. Acta Anaesthesiol Scand 41: 818-823
8. 8. Kermarrec N, Zunic P, Beloucif S, Benessiano J, Dronet L, Payen D (1998) Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxemic lung injury. Am J Respir Crit Care Med 158: 833-839
9. 9. Booke M, Bradford DW, Hinder F, Harper D, Brauchle RW, Traber LD, Traber DL (1996) Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep. Crit Care Med 24: 1841-1848
10. 10. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047
11. 11. Welte M, Zwissler B, Habazettl H, Messmer K (1993) PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 25: 329-340
12. 12. Zwissler B, Welte M, Messmer K (1995) Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction. J Cardiothorac Vasc Anesth 9: 283-289
13. 13. Vane JR, Botting RM (1995) Pharmacodynamic profile of prostacyclin. Am J Cardiol 75: 3A-10A
14. 14. Zwissler B, Kemming G, Habler O, Kleen M, Merkel M, Haller M, Briegel J, Welte M, Peter K (1996) Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 154: 1671-1677
15. 15. Zwissler B, Rank N, Jaenicke U, Schurle B, Welte M, Reichart B, Netz H, Messmer K, Peter K (1995) Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology 82: 1512-1516
16. 16. Walmrath D, Schneider T, Schermuly R, Olschewski H, Grimminger F, Seeger W (1996) Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 153: 991-996
17. 17. Pappert D, Busch T, Gerlach H, Lewandowski K, Radermacher P, Rossaint R (1995) Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 82: 1507-1511
18. 18. Walmrath D, Schneider T, Pilch J, Schermuly R, Grimminger F, Seeger W (1995) Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis. Am J Respir Crit Care Med 151: 724-730
19. 19. Adnot S, Kouyoumdjian C, Defouilloy C, Andrivet P, Sediame S, Herigault R, Fratacci MD (1993) Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 148: 310-316
20. 20. Barbera JA, Roger N, Roca J, Rovira I, Higenbottam T, Rodriguez Roisin R (1996) Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive lung disease. Lancet 347: 436-440
21. 21. Zwissler B, Welte M, Habler O, Kleen M, Messmer K (1995) Effects of inhaled prostacyclin as compared with inhaled nitric oxide in a canine model of pulmonary microembolism and oleic acid edema. J Cardiothorac Vasc Anesth 9: 634-640
22. 22. Rasmussen TR, Kjaergaard SK, Tarp U, Pedersen OF (1992) Delayed effects of NO2 exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am Rev Respir Dis 146: 654-659
23. 23. Higenbottam T, Pepke-Zaba J, Scott J, Woolman P, Coutts C, Wallwork J (1988) Inhaled "endothelium derived-relaxing factor" (EDRF) in primary hypertension. Am Rev Respir Dis 137: 107
24. 24. Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481-487
25. 25. Hallman M, Waffarn F, Bry K, Turbow R, Kleinman MT, Mautz WJ, Rasmussen RE, Bhalla DK, Phalen RF (1996) Surfactant dysfunction after inhalation of nitric oxide. J Appl Physiol 80: 2026-2034
26. 26. Cueto E, Lopez HJ, Sanchez A, Carrillo A (1997) Life-threatening effects of discontinuing inhaled nitric oxide in children. Acta Paediatr 86: 1337-1339
27. 27. Fuller HD, Dolovich MB, Posmituck G, Wong Pack W, Newhouse MT (1989) Pressurized aerosol versus jet aerosol delivery in mechanically ventilated patients. Am Rev Respir Dis 141: 440-444